|
|
| (56 intermediate revisions by 16 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__ | | __NOTOC__ |
| | {| class="infobox" style="float:right;" |
| | |- |
| | | [[File:Siren.gif|30px|link=Acute pancreatitis resident survival guide]]|| <br> || <br> |
| | | [[Acute pancreatitis resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] |
| | |} |
| | '''For patient information, click [[Acute pancreatitis (patient information)|here]]''' |
|
| |
|
| {{Infobox_Disease | | {{Infobox_Disease |
| | Name = Acute pancreatitis | | | Name = Acute pancreatitis |
| | Image = Illu pancrease.jpg | | | | Image = Blausen 0699 PancreasAnatomy2.png |
| | Caption = [[Pancreas]] | | | Caption = Pancreas<ref><https://en.wikipedia.org/wiki/Pancreas#/media/File:Blausen_0699_PancreasAnatomy2.png></ref> |
| | DiseasesDB = 9539
| |
| | ICD10 = {{ICD10|K|85||k|80}}
| |
| | ICD9 = {{ICD9|577.0}}
| |
| | ICDO =
| |
| | OMIM =
| |
| | MedlinePlus = 000287
| |
| | eMedicineSubj = med
| |
| | eMedicineTopic = 1720
| |
| | eMedicine_mult = {{eMedicine2|radio|521}}
| |
| | MeshID =
| |
| }} | | }} |
| {{SI}} | | {{Acute pancreatitis}} |
| | |
| {{CMG}}
| |
| | |
| {{EH}}
| |
| | |
| ==Overview==
| |
| '''Acute [[pancreatitis]]''' is a rapidly-onset [[inflammation]] of the [[pancreas]]. Depending on its severity, it can have severe complications and high mortality despite treatment. While mild cases are often successfully treated with conservative measures, such as [[NPO]] (abstaining from any oral intake) and IV fluid rehydration, severe cases may require admission to the ICU or even surgery (often more than one intervention) to deal with complications of the disease process.
| |
| | |
| ==Epidemiology==
| |
| *Annual incidence in the U.S. is 18 per 100,000 population. In a European cross-sectional study, incidence of acute pancreatits increased from 12.4 to 15.9 per 100,000 annually from 1985 to 1995; however, mortality remained stable as a result of better outcomes.<ref>{{cite journal |author=Eland IA, Sturkenboom MJ, Wilson JH, Stricker BH |title=Incidence and mortality of acute pancreatitis between 1985 and 1995 |journal=Scand. J. Gastroenterol. |volume=35 |issue=10 |pages=1110-6 |year=2000 |pmid=11099067 |doi=}}</ref> Another study showed a lower incidence of 9.8 per 100,000 but a similar worsening trend (increasing from 4.9 in 1963-74) over time.<ref>{{cite journal |author=Goldacre MJ, Roberts SE |title=Hospital admission for acute pancreatitis in an English population, 1963-98: database study of incidence and mortality |journal=BMJ |volume=328 |issue=7454 |pages=1466-9 |year=2004 |pmid=15205290 |doi=10.1136/bmj.328.7454.1466}}</ref>
| |
|
| |
|
| ==Symptoms and signs==
| | {{CMG}}; {{AE}} {{TarekNafee}}; {{IQ}}; {{CZ}}; {{RT}}; |
| | {{SK}} Pancreatitis, acute; acute inflammation of pancreas; acute soreness of pancreas |
|
| |
|
| *Severe upper [[abdominal pain]]
| | ==[[Acute pancreatitis overview|Overview]]== |
| *[[Nausea]], [[vomiting]], [[diarrhea]] and [[loss of appetite]].
| |
| *[[Fever]]/[[Chills]]
| |
| *[[Shock (medical)|Shock]], hemodynamic instability
| |
|
| |
|
| Uncommon
| | ==[[Acute pancreatitis historical perspective|Historical Perspective]]== |
| *[[Grey Turner sign]] (hemorrhagic discoloration of the flanks), [[Cullen sign]] (hemorrhagic discoloration of the umbilicus)
| |
| *[[pancreatic pseudocyst]], [[pancreatic dysfunction]] ([[malabsorption]] due to exocrine failure) or [[diabetes mellitus]].
| |
|
| |
|
| ==Causes== | | ==[[Acute pancreatitis classification|Classification]]== |
| ===Most common causes===
| |
| A common [[mnemonic]] for the causes of pancreatitis spells "I get smashed", an allusion to heavy drinking (one of the many causes):
| |
| *I - [[idiopathic]]
| |
| *G - [[gallstone]]. Gallstones that travel down the common [[bile duct]] and which subsequently get stuck in the [[Ampulla of Vater]] can cause obstruction in the outflow of pancreatic juices from the pancreas into the [[duodenum]]. The backflow of these digestive juices causes lysis (dissolving) of pancreatic cells and subsequent pancreatitis.
| |
| *E - [[ethanol]] ([[alcoholic beverage|alcohol]])
| |
| *T - [[physical trauma|trauma]]
| |
| *S - [[steroids]]
| |
| *M - [[mumps]] ([[paramyxovirus]]) and other viruses ([[Epstein-Barr virus]], [[Cytomegalovirus]])
| |
| *A - [[autoimmune disease]] ([[Polyarteritis nodosa]], [[Systemic lupus erythematosus]])
| |
| *S - scorpion sting - Tityus Trinitatis - Trinidad/ snake bite
| |
| *H - [[hypercalcemia]], [[hyperlipidemia]]/[[hypertriglyceridemia]] and [[hypothermia]]
| |
| *E - [[ERCP]] ('''E'''ndoscopic '''R'''etrograde '''C'''holangio-'''P'''ancreatography - a procedure that combines [[endoscopy]] and [[fluoroscopy]])
| |
| *D - [[Medication|drugs]] ('''SAND''' - [[steroids]] & [[sulfonamides]], [[azathioprine]], [[NSAIDS]], [[diuretics]] such as [[furosemide]] and [[thiazides]], & [[didanosine]]) and [[duodenal ulcer]]s
| |
|
| |
|
| ===Less common causes=== | | ==[[Acute pancreatitis pathophysiology|Pathophysiology]]== |
| * [[pancreas divisum]]
| |
| * long [[common duct]]
| |
| * [[carcinoma]] of the [[head of pancreas]], and other [[cancer]]
| |
| * [[ascaris]] blocking pancreatic outflow
| |
| * [[chinese liver fluke]]
| |
| * [[ischemia]] from [[bypass surgery]]
| |
| * [[fatty necrosis]]
| |
| * [[pregnancy]]
| |
| * [[infection]]s other than mumps, including [[varicella zoster]]
| |
| * repeated marathon running.
| |
| * [[cystic fibrosis]]
| |
|
| |
|
| ===Causes by demographic=== | | ==[[Acute pancreatitis causes|Causes]]== |
| The most common causes of pancreatitis, are as follows :
| |
| * Western countries - chronic alcoholism and gallstones accounting for more than 85% of all cases
| |
| * Eastern countries - gallstones
| |
| * Children - trauma
| |
| * Adolescents and young adults - mumps
| |
|
| |
|
| | ==[[Acute pancreatitis differential diagnosis| Differentiating Acute Pancreatitis from other Diseases]]== |
|
| |
|
| | ==[[Acute pancreatitis epidemiology and demographics|Epidemiology and Demographics]]== |
|
| |
|
| ==Investigations== | | ==[[Acute pancreatitis risk factors|Risk Factors]]== |
| * Blood Investigations - [[Full blood count]], [[kidney|Renal function]] tests, Liver Function, serum calcium, serum amylase and lipase, [[Arterial blood gas]]
| |
| *Imaging - Chest Xray (for exclusion of perforated viscus), Abdominal Xrays (for detection of "sentinel loop" dilated duodenum sign, and gallstones which are radioopaque in 10%) and CT abdomen
| |
|
| |
|
| === '''Amylase and lipase'''=== | | ==[[Acute pancreatitis screening|Screening]]== |
| * Serum amylase and lipase may be used in the making of the diagnosis of acute pancreatitis.
| |
| * Serum amylase usually rises 2 to 12 hours from the onset of symptoms, and normalizes within 48-72 hours.
| |
| * Serum lipase rises 4 to 8 hours from the onset of symptoms and normalizes within 7 to 14 days.
| |
| * Serum amylase may be normal (in 10% of cases) for cases of acute on chronic pancreatitis (depleted acinar cell mass) and hypertriglyceridemia.
| |
| * Reasons for false positive elevated serum amylase include salivary gland disease (elevated salivary amylase) and macroamylasemia.
| |
| * If the lipase level is about 2.5 to 3 times that of Amylase, it is an indication of pancreatitis due to Alcohol <ref name="pmid1718808">{{cite journal |author=Gumaste V, Dave P, Weissman D, Messer J |title=Lipase/amylase ratio. A new index that distinguishes acute episodes of alcoholic from nonalcoholic acute pancreatitis |journal=Gastroenterology |volume=101 |issue=5 |pages=1361-6 |year=1991 |id=PMID 1718808}}</ref>.
| |
|
| |
|
| Regarding selection of these tests, two practice guidelines state:
| | ==[[Acute pancreatitis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== |
|
| |
|
| : "It is usually not necessary to measure both serum amylase and lipase. Serum lipase may be preferable because it remains normal in some nonpancreatic conditions that increase serum amylase including macroamylasemia, parotitis, and some carcinomas. In general, serum lipase is thought to be more sensitive and specific than serum amylase in the diagnosis of acute pancreatitis" <ref name="pmid17032204">{{cite journal |author=Banks P, Freeman M |title=Practice guidelines in acute pancreatitis |journal=Am J Gastroenterol |volume=101 |issue=10 |pages=2379-400 |year=2006 |id=PMID 17032204 | doi=10.1111/j.1572-0241.2006.00856.x}}</ref>
| | ==Diagnosis== |
|
| |
|
| : "Although amylase is widely available and provides acceptable accuracy of diagnosis, where lipase is available it is preferred for the diagnosis of acute pancreatitis (recommendation grade A)"<ref name="pmid15831893">{{cite journal |author=UK Working Party on Acute Pancreatitis |title=UK guidelines for the management of acute pancreatitis |journal=Gut |volume=54 Suppl 3 |issue= |pages=iii1-9 |year=2005 |id=PMID 15831893 | doi=10.1136/gut.2004.057026 | url=http://gut.bmj.com/cgi/content/full/54/suppl_3/iii1}}</ref>
| | [[Acute pancreatitis history and symptoms|History and Symptoms ]] | [[ Acute pancreatitis physical examination|Physical Examination]] | [[Acute pancreatitis laboratory findings|Laboratory Findings]] | [[Acute pancreatitis abdominal x ray| Abdominal X ray]] | [[Acute pancreatitis CT|CT ]] | [[Acute pancreatitis MRI|MRI]] | [[Acute pancreatitis ultrasound|Ultrasound]] | [[Acute pancreatitis other imaging findings|Other Imaging Findings]] | [[Acute pancreatitis other diagnostic studies|Other Diagnostic Studies]] |
| | |
| Most (PMID 15943725, PMID 11552931, PMID 2580467, PMID 2466075, PMID 9436862), but not all (PMID 11156345, PMID 8945483) individual studies support the superiority of the lipase. In one large study, there were no patients with pancreatitis who had an elevated amylase with a normal lipase <ref name="pmid15943725">{{cite journal |author=Smith R, Southwell-Keely J, Chesher D |title=Should serum pancreatic lipase replace serum amylase as a biomarker of acute pancreatitis? |journal=ANZ J Surg |volume=75 |issue=6 |pages=399-404 |year=2005 |id=PMID 15943725 | doi=10.1111/j.1445-2197.2005.03391.x}}</ref>. Another study found that the amylase could add diagnostic value to the lipase, but only if the results of the two tests were combined with a discriminant function equation <ref name="pmid7504593">{{cite journal |author=Corsetti J, Cox C, Schulz T, Arvan D |title=Combined serum amylase and lipase determinations for diagnosis of suspected acute pancreatitis |journal=Clin Chem |volume=39 |issue=12 |pages=2495-9 |year=1993 |id=PMID 7504593}}</ref>.
| |
| | |
| ===Computed tomography===
| |
| Regarding the need for [[computed tomography]], practice guidelines state:
| |
| | |
| : 2006: "Many patients with acute pancreatitis do not require a CT scan at admission or at any time during the hospitalization. For example, a CT scan is usually not essential in patients with recurrent mild pancreatitis caused by alcohol. A reasonable indication for a CT scan at admission (but not necessarily a CT with IV contrast) is to distinguish acute pancreatitis from another serious intra-abdominal condition, such as a perforated ulcer." <ref name="pmid17032204">{{cite journal |author=Banks P, Freeman M |title=Practice guidelines in acute pancreatitis |journal=Am J Gastroenterol |volume=101 |issue=10 |pages=2379-400 |year=2006 |id=PMID 17032204 | doi=10.1111/j.1572-0241.2006.00856.x}}</ref>
| |
| | |
| : 2005: "Patients with persisting organ failure, signs of sepsis, or deterioration in clinical status 6–10 days after admission will require CT (recommendation grade B)."<ref name="pmid15831893">{{cite journal |author=UK Working Party on Acute Pancreatitis |title=UK guidelines for the management of acute pancreatitis |journal=Gut |volume=54 Suppl 3 |issue= |pages=iii1-9 |year=2005 |id=PMID 15831893 | doi=10.1136/gut.2004.057026 | url=http://gut.bmj.com/cgi/content/full/54/suppl_3/iii1}}</ref>
| |
| | |
| CT abdomen should not be performed before the 1st 48 hours of onset of symptoms as early CT (<48 h) may result in equivocal or normal findings.
| |
| | |
| CT Findings can be classified into the following categories for easy recall :
| |
| *Intrapancreatic - diffuse or segmental enlargement, edema, gas bubbles, pancreatic pseudocysts and phlegmons/abscesses (which present 4 to 6 wks after initial onset)
| |
| *Peripancreatic / extrapancreatic - irregular pancreatic outline, obliterated peripancreatic fat, retroperitoneal edema, fluid in the lessar sac, fluid in the left anterior pararenal space
| |
| *Locoregional - Gerota's fascia sign (thickening of inflamed Gerota's fascia, which becomes visible), pancreatic ascites, pleural effusion (seen on basal cuts of the pleural cavity), adynamic ileus,
| |
| | |
| ====Balthazar scoring====
| |
| Balthazar Scoring for the Grading of Acute Pancreatitis
| |
| | |
| The CT Severity Score is the sum of the CT Grade and Necrosis Grade Scores.
| |
| | |
| CT Grade Score
| |
| | |
| {| class="wikitable"
| |
| |-
| |
| ! CT Grade
| |
| ! Appearance on CT
| |
| ! CT Grade Points
| |
| |-
| |
| | Grade A
| |
| | Normal CT
| |
| | 0 points
| |
| |-
| |
| | Grade B
| |
| | Focal or diffuse enlargement of the pancreas
| |
| | 1 point
| |
| |-
| |
| | Grade C
| |
| | Pancreatic gland abnormalities and peripancreatic inflammation
| |
| | 2 points
| |
| |- | |
| | Grade D
| |
| | Fluid collection in a single location
| |
| | 3 points
| |
| |-
| |
| | Grade E
| |
| | Two or more fluid collections and / or gas bubbles in or adjacent to pancreas
| |
| | 4 points
| |
| |}
| |
| | |
| Necrosis score
| |
| | |
| {| class="wikitable"
| |
| |-
| |
| ! Necrosis Percentage !! Points
| |
| |-
| |
| | No necrosis
| |
| | 0 points
| |
| |-
| |
| | 0 to 30% necrosis
| |
| | 2 points
| |
| |-
| |
| | 30 to 50% necrosis
| |
| | 4 points
| |
| |-
| |
| | Over 50% necrosis
| |
| | 6 points
| |
| |}
| |
| | |
| ===Magnetic resonance imaging===
| |
| One study found that a nonenhanced [[magnetic resonance imaging]] (MRI) was comparable to contrast-enhanced [[computed tomography]] (CT).<ref name="pmid17378903">{{cite journal |author=Stimac D, Miletić D, Radić M, ''et al'' |title=The role of nonenhanced magnetic resonance imaging in the early assessment of acute pancreatitis |journal=Am. J. Gastroenterol. |volume=102 |issue=5 |pages=997-1004 |year=2007 |pmid=17378903 |doi=10.1111/j.1572-0241.2007.01164.x}}</ref>
| |
| | |
| ==Classification by severity==
| |
| ===Progression of pathophysiology===
| |
| Acute pancreatitis can be further divided in mild and severe pancreatitis. Mostly the Atlanta classification (1992) is used. In severe pancreatitis serious amount of necrosis determine the further clinical outcome. About 20% of the acute pancreatitis are severe with a mortality of about 20%. This is an important classification as severe pancreatitis will need intensive care therapy whereas mild pancreatitis can be treated on the common ward.
| |
| | |
| Necrosis will be followed by a systemic inflammation response syndrome (SIRS) and will determine the immediate clinical course. The further clinical course is then determined by bacterial infection. SIRS is the cause of bacterial (Gram negative) translocation from the patients colon.
| |
| | |
| There are several ways to help distinguish between these two forms. One is the above mentioned Ranson Score.
| |
| | |
| ===Prognostic indices===
| |
| In predicting the prognosis, there are several scoring indices that have been used as predictors of survival. Two such scoring systems are the Ranson and [[APACHE II]] (Acute Physiology, Age and Chronic Health Evaluation) indices. Most<ref name="pmi2568529">{{cite journal |author=Larvin M, McMahon M |title=APACHE-II score for assessment and monitoring of acute pancreatitis |journal=Lancet |volume=2 |issue=8656 |pages=201-5 |year=1989 |id=PMID 2568529}}</ref> <ref name="pmid16698595">{{cite journal |author=Yeung Y, Lam B, Yip A |title=APACHE system is better than Ranson system in the prediction of severity of acute pancreatitis |journal=Hepatobiliary Pancreat Dis Int |volume=5 |issue=2 |pages=294-9 |year=2006 |id=PMID 16698595 | url=www.hbpdint.com/text.asp?id=837}}</ref>, but not all <ref name="pmid12409825">{{cite journal |author=Chatzicostas C, Roussomoustakaki M, Vlachonikolis I, Notas G, Mouzas I, Samonakis D, Kouroumalis E |title=Comparison of Ranson, APACHE II and APACHE III scoring systems in acute pancreatitis |journal=Pancreas |volume=25 |issue=4 |pages=331-5 |year=2002 |id=PMID 12409825 (comment=this study used a Apache cutoff of >=10) }}</ref> studies report that the Apache score may be more accurate. In the negative study of the Apache II <ref name="pmid12409825">.</ref>, the Apache II 24 hr score was used rather than the 48 hour score. In addition, all patients in the study received at ultrasound twice which may have influenced allocation of co-interventions. Regardless, only the Apache II can be fully calculated upon admission. As the Apache II is more cumbersome to calculate, presumably patients whose only laboratory abnormality is an elevated lipase or amylase do not need prognostication with the Apache II; however, this approach is not studied. The Apache II score can be calculated at [http://www.sfar.org/scores2/apache22.html www.sfar.org].
| |
| | |
| Practice guidelines state:
| |
| :2006: "The two tests that are most helpful at admission in distinguishing mild from severe acute pancreatitis are APACHE-II score and serum hematocrit. It is recommended that APACHE-II scores be generated during the first 3 days of hospitalization and thereafter as needed to help in this distinction. It is also recommended that serum hematocrit be obtained at admission, 12 h after admission, and 24 h after admission to help gauge adequacy of fluid resuscitation."<ref name="pmid17032204">{{cite journal |author=Banks P, Freeman M |title=Practice guidelines in acute pancreatitis |journal=Am J Gastroenterol |volume=101 |issue=10 |pages=2379-400 |year=2006 |id=PMID 17032204 | doi=10.1111/j.1572-0241.2006.00856.x}}</ref>
| |
| | |
| :2005: "Immediate assessment should include clinical evaluation, particularly of any cardiovascular, respiratory, and renal compromise, body mass index, chest x ray, and APACHE II score" <ref name="pmid15831893">{{cite journal |author= Anonymous |title=UK Working Party on Acute Pancreatitis: UK guidelines for the management of acute pancreatitis |journal=Gut |volume=54 Suppl 3 |issue= |pages=iii1-9 |year=2005 |id=PMID 15831893 | doi=10.1136/gut.2004.057026 url=http://gut.bmj.com/cgi/content/full/54/suppl_3/iii1}}</ref>
| |
| | |
| ====Ranson====
| |
| {{main|Ranson criteria}}
| |
| | |
| ====APACHE====
| |
| {{main|APACHE II}}
| |
| "Acute Physiology And Chronic Health Evaluation" ([[APACHE II]]) score > 8 points predicts 11% to 18% mortality <ref name="pmid17032204">.</ref>
| |
| [http://www.sfar.org/scores2/apache22.html Online calculator]
| |
| | |
| *Hemorrhagic peritoneal fluid
| |
| *[[Obesity]]
| |
| *Indicators of organ failure
| |
| *[[Hypotension]] (SBP <90 mmHG) or [[tachycardia]] > 130 beat/min
| |
| *PO<sub>2</sub> <60 mmHg
| |
| *[[Oliguria]] (<50 mL/h) or increasing [[BUN]] and [[creatinine]]
| |
| *Serum calcium < 1.90 mmol/L (<8.0 mg/dL) or serum albumin <33 g/L (<3.2.g/dL)>
| |
|
| |
|
| ==Treatment== | | ==Treatment== |
| ===Pain control===
| | [[Acute pancreatitis medical therapy|Medical Therapy]] | [[Acute pancreatitis surgery|Surgery]] | [[Acute pancreatitis primary prevention|Primary Prevention]] | [[Acute pancreatitis secondary prevention|Secondary Prevention]] | [[Acute pancreatitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acute pancreatitis future or investigational therapies|Future or Investigational Therapies]] |
| Analgesia should not be provided by [[morphine]] because it may cause spasm of the [[sphincter of Oddi]] and worsen the pain, so the drug of choice is [[Meperidine]].
| |
| | |
| ===Bowel rest===
| |
| In the management of acute pancreatitis, the treatment is to stop feeding the patient, giving him or her nothing by mouth, giving [[intravenous]] fluids to prevent [[dehydration]], and sufficient pain control. As the pancreas is stimulated to secrete [[enzyme]]s by the presence of food in the stomach, having no food pass through the system allows the pancreas to rest. Approximately 20% of patients have a relapse of pain during acute pancreatitis.<ref name="pmid17573797">{{cite journal |author=Petrov MS, van Santvoort HC, Besselink MG, Cirkel GA, Brink MA, Gooszen HG |title=Oral Refeeding After Onset of Acute Pancreatitis: A Review of Literature |journal= |volume= |issue= |pages= |year=2007 |pmid=17573797 |doi=10.1111/j.1572-0241.2007.01357.x}}</ref> Approximately 75% of relapses occur within 48 hours of oral refeeding.
| |
| | |
| The incidence of relapse after oral refeeding may be reduced by post-pyloric enteral rather than parenteral feeding prior to oral refeeding.<ref name="pmid17573797"/> IMRIE scoring is also useful.
| |
| | |
| ===Nutritional support===
| |
| Recently, there has been a shift in the management paradigm from TPN ([[total parenteral nutrition]]) to early, post-pyloric enteral feeding (in which a feeding tube is endoscopically or radiographically introduced to the third portion of the duodenum). The advantage of enteral feeding is that it is more physiological, prevents gut mucosal atrophy, and is free from the side effects of TPN (such as [[fungemia]]). The additional advantages of post-pyloric feeding are the inverse relationship of pancreatic exocrine secretions and distance of nutrient delivery from the pylorus, as well as reduced risk of aspiration.
| |
| | |
| Disadvantages of a naso-enteric feeding tube include increased risk of sinusitis (especially if the tube remains in place greater than two weeks) and a still-present risk of accidentally intubating the bronchus even in intubated patients (contrary to popular belief, the endotracheal tube cuff alone is not always sufficient to prevent NG tube entry into the trachea).
| |
| | |
| ===Antibiotics===
| |
| A [[meta-analysis]] by the [[Cochrane Collaboration]] concluded that antibiotics help with a [[number needed to treat]] of 11 patients to reduce mortality <ref name="pmid17054156">{{cite journal |author=Villatoro E, Bassi C, Larvin M |title=Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis |journal=Cochrane Database Syst Rev |volume= |issue= |pages=CD002941 |year= |id=PMID 17054156}}</ref>. However, the one study in the [[meta-analysis]] that used a quinolone, and a subsequent [[randomized controlled trial]] that studied [[ciprofloxacin]] were both negative <ref name="pmid15057739">{{cite journal |author=Isenmann R, Rünzi M, Kron M, Kahl S, Kraus D, Jung N, Maier L, Malfertheiner P, Goebell H, Beger H |title=Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial |journal=Gastroenterology |volume=126 |issue=4 |pages=997-1004 |year=2004 |id=PMID 15057739 | doi = 10.1053/j.gastro.2003.12.050 }}</ref>.
| |
| | |
| ====Carbapenems====
| |
| An early [[randomized controlled trial]] of [[imipenem]] 0.5 gram intravenously every eight hours for two weeks showed a reduction in from pancreatic sepsis from 30% to 12%. <ref name="pmid8480272">{{cite journal |author=Pederzoli P, Bassi C, Vesentini S, Campedelli A |title=A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem |journal=Surgery, gynecology & obstetrics |volume=176 |issue=5 |pages=480-3 |year=1993 |pmid=8480272 |doi=}}</ref>
| |
| | |
| Another [[randomized controlled trial]] with patients who had at least 50% pancreatic necrosis found a benefit from [[imipenem]] compared to [[pefloxacin]] with a reduction in infected necrosis from 34% to 20%<ref name="pmid9834279">{{cite journal |author=Bassi C, Falconi M, Talamini G, ''et al'' |title=Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis |journal=Gastroenterology |volume=115 |issue=6 |pages=1513-7 |year=1998 |pmid=9834279 |doi=}}</ref>
| |
| | |
| A subsequent [[randomized controlled trial]] that used [[meropenem]] 1 gram intravenously every 8 hours for 7 to 21 days stated no benefit; however, 28% of patients in the group subsequently required open antibiotic treatment vs. 46% in the placebo group. In addition, the control group had only 18% incidence of peripancreatic infections and less biliary pancreatitis that the treatment group (44% versus 24%).<ref name="pmid17457158">{{cite journal |author=Dellinger EP, Tellado JM, Soto NE, ''et al'' |title=Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study |journal=Ann. Surg. |volume=245 |issue=5 |pages=674-83 |year=2007 |pmid=17457158 |doi=10.1097/01.sla.0000250414.09255.84}}</ref>
| |
| | |
| ====Summary====
| |
| In summary, the role of antibiotics is controversial. One recent expert opinion (prior to the last negative trial of [[meropenem]]<ref name="pmid17457158"/>) suggested the use of [[imipenem]] if CT scan showed more than 30% necrosis of the pancreas.<ref name="pmid16707751">{{cite journal |author=Whitcomb D |title=Clinical practice. Acute pancreatitis |journal=N Engl J Med |volume=354 |issue=20 |pages=2142-50 |year=2006 |id=PMID 16707751 | doi=10.1056/NEJMcp054958 | url=http://content.nejm.org/cgi/content/full/354/20/2142}}</ref>
| |
| | |
| ===ERCP===
| |
| Early '''ERCP''' ([[endoscopic retrograde cholangiopancreatography]]), performed within 24 to 72 hours of presentation, is known to reduce morbidity and mortality.<ref>{{cite book |title=The Intensive Care Manual |last=Apostolakos |first=Michael J. |coauthors=Peter J. Papadakos |year=2001 |publisher=McGraw-Hill Professional |isbn=0070066965}}</ref> The indications for early ERCP are as follows :
| |
| * Clinical deterioration or lack of improvement after 24 hours
| |
| * Detection of common bile duct stones or dilated intrahepatic or extrahepatic ducts on CT abdomen
| |
| The disadvantages of ERCP are as follows :
| |
| * ERCP precipitates pancreatitis, and can introduce infection to sterile pancreatitis
| |
| * The inherent risks of ERCP i.e. bleeding
| |
| | |
| It is worth noting that ERCP itself can be a cause of pancreatitis.
| |
| | |
| ===Surgery===
| |
| Surgery is indicated for (i) infected pancreatic necrosis and (ii) diagnostic uncertainty and (iii)complications. The most common cause of death in acute pancreatitis is secondary infection. Infection is diagnosed based on 2 criteria
| |
| *Gas bubbles on CT scan (present in 20 to 50% of infected necrosis)
| |
| *Positive bacterial culture on FNA (fine needle aspiration, usually CT or US guided) of the pancreas.
| |
| | |
| Surgical options for infected necrosis include:
| |
| *Conventional management - necrosectomy with simple drainage
| |
| *Closed management - necrosectomy with closed continuous lavage
| |
| *Open management - necrosectomy with planned staged reoperations at definite intervals (up to 7 reoperations in some cases)
| |
| | |
| ===Other measures===
| |
| *Pancreatic enzyme inhibitors are not proven to work.<ref>{{cite book |title=Current Obstetric & Gynecologic Diagnosis & Treatment |last=DeCherney |first=Alan H. |coauthors=Lauren Nathan |year=2003 |publisher=McGraw-Hill Professional |isbn=0838514014}}</ref>
| |
| *The use of [[octreotide]] has not been shown to improve outcome.<ref>{{cite book |title=The Trauma Manual: Trauma and Acute Care Surgery |last=Peitzman |first=Andrew B. |coauthors=C. William Schwab, Donald M. Yealy, Timothy C. Fabian |year=2007 |publisher=Lippincott Williams
| |
| & Wilkins |isbn=0781762758}}</ref>
| |
| | |
|
| |
|
| ==Complications== | | ==Case Studies== |
| Complications can be systemic or locoregional.
| | [[Acute pancreatitis case study one|Case #1]] |
| * Systemic complications include [[Acute respiratory distress syndrome|ARDS]], [[multiple organ dysfunction syndrome]], [[diffuse intravascular coagulation|DIC]], [[hypocalcemia]] (from fat saponification), [[hyperglycemia]] and [[diabetes mellitus|insulin dependent diabetes mellitus]] (from pancreatic insulin producing [[beta cell]] damage)
| |
| * Locoregional complications include pancreatic pseudocyst and phlegmon / abscess formation, splenic artery pseudoaneurysms, hemorrhage from erosions into splenic artery and vein, thrombosis of the splenic vein, superior mesenteric vein and portal veins (in descending order of frequency), duodenal obstruction, common bile duct obstruction, progression to chronic pancreatitis
| |
|
| |
|
| | ==Related Chapters== |
| | *[[Chronic pancreatitis|Chronic Pancreatitis]] |
|
| |
|
|
| |
| ==See also==
| |
| * [[Chronic pancreatitis]]
| |
|
| |
| ==References==
| |
| {{reflist|2}}
| |
|
| |
| ==External links==
| |
| *[http://videos.med.wisc.edu/videoInfo.php?videoid=221 VIDEO: Complications of Acute Pancreatitis: Management and Outcomes], Mark Malangoni, MD, speaks at the University of Wisconsin School of Medicine and Public Health (2007)
| |
|
| |
| *[http://www.surgery.usc.edu/divisions/tumor/PancreasDiseases/web%20pages/PANCREATITIS/what%20is%20acute%20pancreatitis.html Medical Information and Treatment of Acute Pancreatitis]
| |
|
| |
| *[http://www.medstudents.com.br/gastro/gastro1.htm Mechanisms of Disease: Etiology and Pathophysiology of Acute Pancreatitis]
| |
|
| |
| {{SIB}}
| |
| {{Gastroenterology}} | | {{Gastroenterology}} |
|
| |
|
| |
| [[Category:Medical emergencies]]
| |
| [[Category:Gastroenterology]]
| |
| [[Category:Surgery]]
| |
| [[Category:Emergency medicine]]
| |
|
| |
| [[de:Akute Pankreatitis]] | | [[de:Akute Pankreatitis]] |
| [[fr:Pancréatite aiguë]] | | [[fr:Pancréatite aiguë]] |
| Line 287: |
Line 58: |
| [[ru:Острый панкреатит]] | | [[ru:Острый панкреатит]] |
| [[sl:Akutni pankreatitis]] | | [[sl:Akutni pankreatitis]] |
| | [[tr:Akut pankreatit]] |
| | |
|
| |
|
| {{WikiDoc Help Menu}} | | {{WikiDoc Help Menu}} |
| {{WikiDoc Sources}} | | {{WikiDoc Sources}} |
| | |
| | [[Category:Gastroenterology]] |
| | [[Category:Surgery]] |
| | [[Category:Emergency medicine]] |
| | [[Category:Disease]] |
